2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.28+$0.004 (+1.58%)
Price as of Sep 11, 2026 7:47 PM EDT- $28.8MMarket Cap
- -31.36%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.28+$0.004 (+1.58%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.28 | ||
Change | -$0.004 (-1.55%) | ||
Open | $0.29 | ||
High | $0.29 | ||
Low | $0.28 | ||
Previous Close | $0.28 | ||
Volume | 415,678 | ||
30-Day Average Volume | 974,082 | ||
1-Week Change | -6.51% | ||
1-Month Change | -0.85% | ||
1-Year Change | -31.36% | ||
3-Year Change | -39.43% | ||
5-Year Change | -81.79% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $9.5M | ||
Market Cap | $28.8M | ||
Enterprise Value | $29.6M | ||
Period: QTR TTM FY | |||
Revenue | $265,000.00 | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$1.4M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | -$2.0M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 112 | ||
P/B | 5 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue